Analysis of immune responses in COVID-19 patients identifies defining features of severe disease

July 15, 2020

An analysis of immune responses in 42 COVID-19 patients, both infected and recovered, identified immune signatures that distinguish severe COVID-19 cases. Notably, the analysis features insights not only into adaptive immune cell responses, but also those of innate immune cells responding to the virus. The findings will inform development of COVID-19 therapeutics. As the global COVID-19 pandemic continues, knowledge of the immunological signatures of severe COVID-19 is continually evolving. Whether there is a common profile of immune dysfunction in critically ill COVID-19 patients remains a question. To date, studies investigating this are limited, reporting on single patients or small cohorts. Seeking to expand upon them, Leticia Kuri-Cervantes and colleagues - a group overlapping in part with authors of the study by Mathew et al. published in Science today (15 July, 2020) - performed a high dimensional flow cytometry analysis on immune cells in blood from 42 COVID-19 patients with varying levels of disease state (moderate, severe, and recovered). Consistent with previous reports, they identified (and further defined) a characteristic immune phenotype in severe COVID-19 patients - distinct from the response in both healthy donors and also in COVID-19 patients with moderate or recovered disease. They also uncovered changes in the innate immune system - circulating neutrophils, monocytes and natural killer cells - in severe COVID-19 patients, though whether these are a "consequence or contributing factor towards COVID-19 severity remains to be defined," they say. The authors suggest the immune dysregulation they observed in severe COVID-19 patients "may necessitate targeted strategies to effectively manage clinical care" for this group. Longitudinal studies will be needed, they say, to determine whether early detection of these immunological perturbations predict severe disease trajectory in patients who are asymptomatic or have mild disease.

American Association for the Advancement of Science

Related Immune Cells Articles from Brightsurf:

Gut immune cells may help send MS into remission
An international research team led by UCSF scientists has shown, for the first time, that gut immune cells travel to the brain during multiple sclerosis (MS) flare-ups in patients.

Immune cells sculpt circuits in the brain
Brain immune cells, called microglia, protect the brain from infection and inflammation.

How tumor cells evade the immune defense
Scientists are increasingly trying to use the body's own immune system to fight cancer.

Breast cancer cells can reprogram immune cells to assist in metastasis
Johns Hopkins Kimmel Cancer Center investigators report they have uncovered a new mechanism by which invasive breast cancer cells evade the immune system to metastasize, or spread, to other areas of the body.

Breast cancer cells turn killer immune cells into allies
Researchers at Johns Hopkins University School of Medicine have discovered that breast cancer cells can alter the function of immune cells known as Natural killer (NK) cells so that instead of killing the cancer cells, they facilitate their spread to other parts of the body.

Engineered immune cells recognize, attack human and mouse solid-tumor cancer cells
CAR-T therapy has been used successfully in patients with blood cancers such as lymphoma and leukemia.

Mapping immune cells in brain tumors
It is not always possible to completely remove malignant brain tumors by surgery so that further treatment is necessary.

Nutrient deficiency in tumor cells attracts cells that suppress the immune system
A study led by IDIBELL researchers and published this week in the American journal PNAS shows that, by depriving tumor cells of glucose, they release a large number of signaling molecules.

Experience matters for immune cells
The discovery that immune T cells have a spectrum of responsiveness could shed light on how our immune system responds to infections and cancer, and what goes wrong in immune diseases.

Immune cells against Alzheimer's?
German researchers have developed a novel, experimental approach against Alzheimer's.

Read More: Immune Cells News and Immune Cells Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to